Surgical Field / Wound Infiltration Market Analysis

Nerve Blocks Market to Reach USD 9.4 Billion by 2033 at 6.4% CAGR

Direct wound infiltration of local anesthetic, distinct from targeted nerve block, is frequently used in outpatient procedures and minor surgery. Liposomal bupivacaine (Exparel) was initially approved for this route, and it constitutes the majority of Exparel volume. Growth tracks ASC procedure volume expansion closely. Reimbursement coding for wound infiltration is less favorable than for named nerve block CPT codes, creating a structural gross-to-net disadvantage relative to ultrasound-guided peripheral blocks.